News & Events
ChemGenex Presents Updated Analysis at ASH on OMAPROâ?˘in CML Patients who Failed Two or Three Approved TKI Drugs
06 / 12 / 2010
Sunshine Heart successfully completes $9.5 million capital raising with close of non-renounceable rights offer
03 / 12 / 2010
Euthymics Bioscience, Inc. Appoints Biotech Industry Veteran Walter Piskorski as Vice President, Technical Operations
18 / 11 / 2010
EUTHYMICS BIOSCIENCE, INC. NAMES BIOTECH EXECUTIVE TIMOTHY J. BARBERICH TO BOARD OF DIRECTORS
04 / 11 / 2010
Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer
01 / 11 / 2010
ChemGenex Announces Convertible Note Issue and Welcomes Cephalon, Inc. as a Substantial Investor
22 / 10 / 2010
ChemGenex Completes pre-NDA Meeting with U.S. FDA and Clarifies Timing for Second New Drug Application for OMAPROTM
06 / 10 / 2010
CoDa Therapeuticsâ?? NEXAGON® Wound Healing Gel Named to Windhoverâ??s â??Top 10 HOT SPACE Projects to Watchâ?ť
17 / 09 / 2010
Sunshine Heart Announces First Minimally Invasive Thoracotomy Procedures Performed for the C-Pulse® Heart Assist System
31 / 08 / 2010
AIMEDICS secures funding for the commercialisation of its overnight hypoglycaemia monitor
27 / 08 / 2010
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader
17 / 08 / 2010
Viveve-Sponsored Research Accepted for Presentation at Two Prestigious International Conferences
13 / 07 / 2010
UPTAKE MEDICAL COMPLETES SERIES B FINANCING ROUNDFOR $17.5 MILLION -Seattle, Wash. and Irvine, Calif., USA
07 / 07 / 2010
CoDa Therapeutics Achieves Positive Phase 2 Efficacy of NEXAGON® in Chronic Venous Leg Ulcers
29 / 06 / 2010
Displaying records 401-425 of 705